Cargando…
Steroid-Refractory Insulin Autoimmune Syndrome Treated With Rituximab and Continuous Glucose Monitoring
A 67-year-old female presented with severe hypoglycemia with a blood glucose of 34 mg/dl five hours after having dinner. She did not have diabetes and had no access to oral hypoglycemic agents, insulin, or any other drug known to cause hypoglycemia. She was a known case of primary hypothyroidism eut...
Autores principales: | Batra, Chandar M, Kumar, Kiran, Goyal, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375604/ https://www.ncbi.nlm.nih.gov/pubmed/34430127 http://dx.doi.org/10.7759/cureus.16513 |
Ejemplares similares
-
D1 MTE1 Case 1: Steroid refractory insulin autoimmune syndrome treated with rituximab and continuous glucose monitoring
por: Batra, Chandar M, et al.
Publicado: (2022) -
Type 2 Decompensated Diabetes Mellitus Weaned off Subcutaneous Insulin Therapy by Utilizing a Continuous Glucose Monitoring Device
por: Manov, AndreyI, et al.
Publicado: (2023) -
Continuous Glucose Monitoring vs. Capillary Blood Glucose in Hospitalized Type 2 Diabetes Patients
por: Veríssimo, David, et al.
Publicado: (2023) -
Unmasking Type 1 Diabetes in Adults: Insights From Two Cases Revealing Misdiagnosis As Type 2 Diabetes, With Emphasis on Autoimmunity and Continuous Glucose Monitoring
por: Manov, Andre E, et al.
Publicado: (2023) -
Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-analysis
por: Janapala, Rajesh Naidu, et al.
Publicado: (2019)